State of New Jersey Common Pension Fund D
AMLX icon

State of New Jersey Common Pension Fund D’s Amylyx Pharmaceuticals AMLX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$417K Buy
23,232
+713
+3% +$11K ﹤0.01% 1643
2026
Q1 		$313K Buy
+22,519
New +$317K ﹤0.01% 1500

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

State of New Jersey Common Pension Fund D's AMLX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D increased its Amylyx Pharmaceuticals (AMLX) stake by 3.2% in Q2 2026, buying an estimated $11K and bringing the position to 23,232 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

State of New Jersey Common Pension Fund D first reported a position in AMLX in Q1 2026 and has held it in 2 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 23,232 shares of Amylyx Pharmaceuticals worth $417K as of Q2 2026.
  • State of New Jersey Common Pension Fund D bought 713 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $11K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1643 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Amylyx Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.